Biotage Archives - Scientific Technology News

February 18, 2020 Product Launch

Good Laboratory Practices Software Upgrade for Biotage® Extrahera™

UPPSALA, Sweden , February 18, 2020 / B3C newswire / — Biotage AB (Biotage), (NASDAQ OMX Stockholm: BIOT.ST) is pleased to announce the launch of a Good Laboratory Practices (GLP) software upgrade for Biotage® Extrahera™, their flagship automated sample preparation instrument for Supported Liquid Extraction (SLE), Solid Phase Extraction (SPE), Phospholipid Depletion (PLD) and Protein Precipitation (PPT). Biotage customers can now harness... Read more

May 24, 2019 PR/Corporate

Tomas Blomquist – new CEO & President of Biotage

FRI, MAY 24, 2019 18:00 CET Contact persons:Torben Jörgensen, CEOTel: +46 707 49 05 84, torben.jorgensen@biotage.comThomas Eklund, Chairman of the BoardTel: +46 (0)708 24 20 25, thomas.eklund@investorab.com Uppsala, Biotage AB (Biotage), (NASDAQ OMX Stockholm: BIOT.ST) – Biotage has appointed Tomas Blomquist as the new CEO and President of Biotage AB. Tomas Blomquist, most recently Vice President EMEA... Read more

April 17, 2019 Chromatography PR/Corporate

Biotage AB – changes in Nomination Committee proposal

WED, APR 17, 2019 10:00 CET Stockholm, Biotage AB (Biotage), (NASDAQ OMX Stockholm: BIOT.ST) – The Nomination Committee of Biotage has been informed that Reinhardt Vogt, who has been nominated to be elected as a Biotage Board member at the 24 April 2019 AGM, no longer is available for the assignment.As previously communicated by the... Read more

January 15, 2019 Chromatography Lab Equipment M&A, Partnerships

Biotage completes the acquisition of PhyNexus, Inc. and resolves on a share issue as part of the acquisition

TUE, JAN 15, 2019 18:15 CET Stockholm – Biotage AB (publ) (Biotage) has today completed the acquisition of PhyNexus, Inc. (PhyNexus), which was announced on December 4, 2018. As part of the completion, the Board of Directors of Biotage has also, pursuant to an authorization granted by the Annual General Meeting 2018, resolved on a... Read more

January 2, 2019 Chromatography PR/Corporate

The Nomination Committee of Biotage AB proposes a new director

WED, JAN 02, 2019 08:45 CET Biotage AB (Biotage), (Nasdaq Stockholm: BIOT.ST) – for the upcoming Annual General Meeting 2019 in Biotage AB, the Nomination Committee today publishes its proposal that the current CEO Torben Jørgensen shall be elected as a new board member. Proposals for other matters and other Directors will be published later.... Read more

December 4, 2018 M&A, Partnerships

Biotage acquires PhyNexus, Inc. and strengthens its position in lab-scale purification of biomolecules

TUE, DEC 04, 2018 07:45 CET Stockholm – Biotage AB (publ) (Biotage), (Nasdaq Stockholm: BIOT.ST) has today entered into an agreement to acquire all outstanding shares in the privately held company PhyNexus, Inc. (PhyNexus) based in California, US, for a total purchase price of approx. USD 21.5 million (corresponding to approx. SEK 195 million[1]) financed... Read more

December 4, 2018 Chromatography M&A, Partnerships

PhyNexus, Inc. Enters Into An Agreement To Be Acquired By Biotage AB

SAN JOSE, Calif., Dec. 4, 2018 /PRNewswire/ — PhyNexus, Inc., a privately held California corporation, announces today an agreement to be acquired by Biotage AB (Nasdaq Stockholm: BIOT.ST), strengthening its position for world-wide sales and marketing of automated lab-scale purification technology of biomolecules. Together, PhyNexus and Biotage will be able to provide their global customers an enabling automation platform... Read more

November 5, 2018 Chromatography PR/Corporate

Biotage AB (publ) publishes new Financial Goals

MON, NOV 05, 2018 17:30 CET Biotage has two financial goals in its business, an organic sales growth goal of 8 percent and a profitability goal on EBIT- level of 15 percent. The EBIT-goal is now adjusted up to 20 percent based on the beneficial development of the business. The organic sales growth goal remains... Read more

May 9, 2018 PR/Corporate

Biotage and CEO Torben Jörgensen have agreed to extend period of service

WED, MAY 09, 2018 14:00 CETBiotage’s Board of Directors and Torben Jörgensen have agreed to extend Torben Jörgensen’s current employment contract as Biotage’s CEO and President up and until April 2020 when Torben Jörgensen will be 68 years old. According to the previous contract, Torben Jörgensen would leave Biotage April 2019. This information was submitted... Read more

March 5, 2018 Chromatography PR/Corporate

Biotage AB –Nomination Committee proposal for the election of Board of Directors and Chairman of the Board

MON, MAR 05, 2018 08:30 CETStockholm, Biotage AB (Biotage), (NASDAQ OMX Stockholm: BIOT.ST) – the Nomination Committee of Biotage AB announces its proposal for the election of the Board of Directors and Chairman of the Board for the forthcoming Annual General Meeting (“AGM”). The Nomination Committee proposes: that the Board of Directors shall consist of... Read more